Zum Hauptinhalt springen
Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Für diesen Artikel ist leider kein Bild verfügbar.

Clostridioides difficile

Diagnostic and Clinical Perspectives
Buch | Softcover
176 Seiten
2026
CRC Press (Verlag)
9781032950914 (ISBN)
CHF 69,80 inkl. MwSt
  • Noch nicht erschienen (ca. Mai 2026)
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken
This book is a practical guide for clinicians and other healthcare providers on a holistic approach to understanding and managing Clostridioides difficile infection. It covers pathophysiology, the role of the microbiome, diagnostic testing, management guidelines, and treatment options, including newly approved therapeutics. It also describes the patient experience and burden of C. difficile, treatment and clinical care pathways, patient education, and economic considerations. The topics covered are based on identified real-world needs of microbiologists, clinicians and patients and include updates on treatment and data.

Key Features:



Provides an engaging transfer of knowledge through visual clinical decision-making tools, best practices, and patient perspectives described by thought leaders and patients.
Offers an updated method of understanding the “how and why” the newest treatments work to allow the clinician the opportunity to understand how to optimize therapeutics.

Glenn Tillotson PhD, FIDSA, FCCP Glenn Tillotson is a Partner at GST Micro, a microbiologist consultant to the pharmaceutical and diagnostic industries, He provides support for both medical affairs and commercialization programs for companies, most notably in the infectious disease area. Glenn has had a number of senior roles in the pharmaceutical industry with over 40 years’ pharmaceutical experience, in clinical research, commercialization, scientific communications including publications planning, strategic drug development, life cycle management, and global launch programs. Glenn has published over 230 articles, 5 textbook chapters, been a member of several editorial advisory boards including Lancet Infectious Diseases, has been a member of scientific steering committees for a range of international congresses, and has been involved in several Clostridioides difficile programs. He is a fellow of IDSA and American College of Chest Physicians and is currently Editor in Chief of Expert Review of Anti-Infective Therapy journal. Paul Feuerstadt, MD, FACG, AGAF Dr. Paul Feuerstadt is a gastroenterologist practicing at the PACT-Gastroenterology Center and is an Associate Clinical Professor of Medicine at the Yale School of Medicine. Dr. Feuerstadt’s focuses include the microbiota, C. difficile infection, eosinophilic disorders, intestinal ischemia, acute and chronic changes in bowel habits. He has been a principal investigator on numerous clinical trials in these spaces. Within his practice he is very active in teaching and volunteer work locally and nationally for disease and discipline specific initiatives. Dr. Feuerstadt has authored and co-authored many manuscripts and textbook chapters. Another passion of Dr. Feuerstadt’s is teaching, frequently giving lectures locally, regionally, nationally and internationally. He works extensively with the gastroenterology fellows in the division of digestive disease at Yale-New Haven Hospital. His clinical practice at the PACT Gastroenterology Center is his ultimate passion filling the majority of his work time. Nicolette Theriault, MPH Nicolette in a researcher and analyst in independent medical education outcomes, focusing on transforming data into actionable insights to improve medical education and patient outcomes. She has diverse background in health education programming, medical writing, and public health research, she brings a multidisciplinary approach to measuring impact. Nicolette has authored and co-authored multiple manuscripts in the infectious disease and medical education space. Nicolette holds a BA from Quinnipiac University and a master’s in international public health from the University of Liverpool.

Clostridioides difficile -Restrictive and -Permissive Gut Microbiomes: A Review
Clostridioides difficile diagnostic testing
Diagnosis and Management of Clostridioides difficile in patients with Inflammatory Bowel Disease
Antimicrobial and biologic therapeutics utilized for the treatment of Clostridioides difficile
A Comparative Review of GI and ID Guidelines for Clostridioides difficile Treatment
Microbiota-based therapies for Clostridioides difficile
Transitions of care associated with Clostridioides difficile infection
Nursing and Patient Perspective Clostridioides difficile infection
The health-related quality of life aspects of Clostridioides difficile infection
Economics of Clostridioides difficile

Erscheint lt. Verlag 22.5.2026
Zusatzinfo 4 Tables, black and white; 3 Line drawings, color; 4 Line drawings, black and white; 3 Halftones, color; 4 Halftones, black and white; 6 Illustrations, color; 8 Illustrations, black and white
Verlagsort London
Sprache englisch
Maße 129 x 198 mm
Themenwelt Medizinische Fachgebiete Innere Medizin Gastroenterologie
Medizin / Pharmazie Pflege Altenpflege
Studium Querschnittsbereiche Infektiologie / Immunologie
ISBN-13 9781032950914 / 9781032950914
Zustand Neuware
Informationen gemäß Produktsicherheitsverordnung (GPSR)
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
revolutionäres Wissen für unsere psychische und körperliche …

von Gregor Hasler

Buch | Softcover (2025)
Klett-Cotta (Verlag)
CHF 25,90